Stories of Technology, Innovation, & Entrepreneurship in the Southeast

Knoxville Business News Tennessee Mountain Scenery Background
October 29, 2023 | Tom Ballard

Four start-ups will compete in next week’s “Venture Forum”

A cash prize of $10,000 is up for grabs when they pitch their companies during LSTCON.

Four start-ups – one each from Knoxville and Memphis and two from Nashville – will compete for the $10,000 prize during the annual “Venture Forum” that will conclude next week’s Life Science Tennessee conference.

Known by its acronym LSTCON, the event on November 8 will feature these competitors:

  • Orion Therapeutics Inc., a Knoxville-based therapeutic company that has developed a lipid nanoparticle delivery system platform for gene therapies that accelerates early stage RNA programs to market by providing a safe, effective, scalable, and targeted delivery system for a broad range of disease applications to ultimately meet unmet clinical need.
  • EndoShunt, a Nashville-based medical device company that is developing a first-of-its-kind temporary, minimally invasive hemorrhage control device that creates a size adjustable channel inside the inferior vena cava (IVC) or aorta – ensuring a patient’s blood continues to flow to where it should without flowing out of where it shouldn’t.
  • MiCare Path, a Memphis-based digital health care solution that connects patients and providers with both the technology and personalized care service proven to increase patient engagement in their care, improve critical health outcomes, and reduce hospital readmissions. The start-up has created a reimbursable, universal enterprise platform consisting of 12+ connected devices, a cloud system with data aggregation and clinical workflows, actionable visual analytics in support of population health, and a mobile app with short message service (SMS), patient education, and engagement.
  • VoluMetrix, another Nashville-based medical device company dedicated to creating a new wave of solutions for vital monitoring to enhance well-being. As the pioneers of non-invasive venous waveform technology, VoluMetrix is partnering closely with patients and practitioners to develop pathways toward the optimal implementation and utilization of their technology, from hospital to home.

The cash prize is sponsored by Holland & Knight.

Like what you've read?

Forward to a friend!

Don’t Miss Out on the Southeast’s Latest Entrepreneurial, Business, & Tech News!

Sign-up to get the Teknovation Newsletter in your inbox each morning!

  • This field is for validation purposes and should be left unchanged.

No, thanks!